SCHEMBL28486352

SCHEMBL28486352

CCOC(=O)C(=O)NNC(=O)C1CCCN1C(=O)OC(C)(C)C

nearest known ligand 0.60

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.60
MEN1 O00255 3/20 0.60
SMN1; SMN2 Q16637 1/20 0.53
LMNA P02545 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
NPC1 O15118 1/20 0.50
ALDH1A1 P00352 1/20 0.47
HSD17B10 Q99714 1/20 0.47
POLB P06746 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.45
SCN5A Q14524 1/20 0.43
SCN3A Q9NY46 1/20 0.43
USP30 Q70CQ3 1/20 0.43
SCN4A P35499 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21452369 1.00 KMT2A (0.60) KMT2AMEN1SMN1; SMN2LMNANPSR1
SCHEMBL14430999 0.84 KMT2A (0.56) KMT2AMEN1SMN1; SMN2LMNANPSR1
SCHEMBL28542976 0.83 TSHR (0.41) KMT2AMEN1SMN1; SMN2LMNANPSR1
SCHEMBL28542978 0.83 TSHR (0.41) KMT2AMEN1SMN1; SMN2LMNANPSR1
SCHEMBL20002160 0.83 KMT2A (0.56) KMT2AMEN1SMN1; SMN2LMNANPSR1
SCHEMBL17069031 0.82 NPC1 (0.59) KMT2AMEN1SMN1; SMN2LMNANPSR1
SCHEMBL4436777 0.81 SMN1; SMN2 (0.60) KMT2AMEN1SMN1; SMN2LMNANPSR1
SCHEMBL28916508 0.81 KMT2A (0.55) KMT2AMEN1SMN1; SMN2LMNANPSR1
SCHEMBL28915732 0.81 KMT2A (0.55) KMT2AMEN1SMN1; SMN2LMNANPSR1
SCHEMBL18374165 0.81 SMN1; SMN2 (0.60) KMT2AMEN1SMN1; SMN2LMNANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111936475-B Immunomodulator, composition and preparation method thereof 贝达药业股份有限公司 2024-05-10 CN disclosed
CN-111936475-A Immunomodulator, composition and preparation method thereof 贝达药业股份有限公司 2020-11-13 CN disclosed